A detailed history of Capital Performance Advisors LLP transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 249 shares of AVNS stock, worth $4,658. This represents 0.0% of its overall portfolio holdings.

Number of Shares
249
Holding current value
$4,658
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$19.21 - $24.69 $4,783 - $6,147
249 New
249 $5,000

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $870M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Capital Performance Advisors LLP Portfolio

Follow Capital Performance Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Performance Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Capital Performance Advisors LLP with notifications on news.